For example, one analysis found that patients taking a GLP-1 drug had a 3.67 times higher risk of gastroparesis compared to patients who took bupropion-naltrexone, a different weight-loss drug
This paper examines the current landscape of peptide-based medicines, exploring their biological mechanisms, clinical applications, safety considerations, and regulatory pathways
Department of Health and Human Services issued a report warning that dozens of weight loss and immune system supplements have illegal claims of curing or treating disease on their labels and/or lack the scientific evidence to support such label claims
Shi H, Li Q-Y, Li H, Wang H-Y, Fan C-X, Dong Q-Y, et al